Immunex' Leukine approved for allogeneic bone marrow transplantation; GM-CSF's fourth indication.
Executive Summary
IMMUNEX LEUKINE APPROVED FOR ALLOGENEIC BMT in HLA-matched related donors Nov. 24. Immunex' yeast-derived granulocyte-macrophage colony stimulating factor (sargramostim) was found to "shorten time to white blood cell count recovery, to decrease the length of hospital stay after the procedure and to reduce the overall incidence of infection," Immunex said Nov. 29.